Previous Page
11-09 :: September 2011
nanotimes Patents
ding to the patent, NanoCap has potentially higher energy storage densities compared to existing lithium ion batteries. The device has low weight, enhanced capacitance and higher power. Once completely de- veloped, NanoCap can be used to power an exten- sive range of applications such as consumer batteries used in computers and cell phones, transistor gate dielectrics, transportation, telecommunication infra- structure and energy storage system, specifically for storing renewable energy.
h t t p : / / p a t f t . u s p t o . g o v / n e t a c g i / n p h - Parser?patentnumber=7990679
57
pharmacological effects and a considerably improved quality of patients’ life.
The product is of particular interest for pharmaceuti- cal manufacturers and developers of active agents for the treatment of pulmonary hypertension.
Contact: TransMIT GmbH, Ms. Iris Stallkamp, Kerkrader Str. 3, D-35394 Giessen, Germany, Phone: +49-(0)641- 94364-33
h t t p : / /www. h i p o - o n l i n e . d e / u k / u k _ d own -
load.cfm?expose_Id=566&pdf_name=TM543_ Expose_200611b_englisch_2011-08-10.pdf
Nanoparticles for Sustained Release of Active Agents for the Treatment of Pulmonary Hypertension
Inventor(s): Tobias Gessler, Thomas Kissel, Thomas Schmehl, Moritz Beck-Broichsitter
Abstract: Pulmonary hypertension is a serious, lifethreatening disorder which substantially restricts physical capaci- ties and results in a severely reduced life expectancy with an average survival time of only 2.8 years after diagnosis if the disease is not treated. The new nano- particles now allow a controlled release of inhalable active agents for pulmonary hypertension over a long period of time, thus leading to a prolongation of
Substances for the Effective Stimulation of Natriuretic Peptide Receptors
Inventor(s): Thomas Walther, Anja Schwiebs
Abstract: The natriuretic system in humans and animals com- prises receptors for the atrial natriuretic peptide (ANP), the B-type natriuretic peptide (BNP), and the C-type natriuretic peptide (CNP), and plays an essen- tial role in regulating blood pressure and the body‘s fluid balance. The natriuretic peptides which bind to the relevant receptors cause blood pressure to decre- ase and water excretion via urine to increase. Fur- thermore, they comprise direct cardioprotective and antifibrotic effects.